Cargando…

A review of the presentation and outcome of left ventricular thrombus in coronavirus disease 2019 infection

BACKGROUND: Cardiovascular complications of the coronavirus disease 2019 (COVID-19), which is caused by the severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2), have been documented both in the acute phase and in convalescence. One such complication is the formation of the left ventricular...

Descripción completa

Detalles Bibliográficos
Autores principales: Philip, Anil Mathew, George, Lina James, John, Kevin John, George, Anu Anna, Nayar, Jemimah, Sahu, Kamal Kant, Selvaraj, Vijairam, Lal, Amos, Mishra, Ajay Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Whioce Publishing Pte. Ltd. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8715711/
https://www.ncbi.nlm.nih.gov/pubmed/34988332
_version_ 1784624183924228096
author Philip, Anil Mathew
George, Lina James
John, Kevin John
George, Anu Anna
Nayar, Jemimah
Sahu, Kamal Kant
Selvaraj, Vijairam
Lal, Amos
Mishra, Ajay Kumar
author_facet Philip, Anil Mathew
George, Lina James
John, Kevin John
George, Anu Anna
Nayar, Jemimah
Sahu, Kamal Kant
Selvaraj, Vijairam
Lal, Amos
Mishra, Ajay Kumar
author_sort Philip, Anil Mathew
collection PubMed
description BACKGROUND: Cardiovascular complications of the coronavirus disease 2019 (COVID-19), which is caused by the severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2), have been documented both in the acute phase and in convalescence. One such complication is the formation of the left ventricular (LV) thrombus. There is a lack of clarity regarding the incidence, risk factors, and management of this complication. AIM: The aim of the study is to identify the clinical presentation, risk factors and outcome of COVID-19 patients with left ventricular thrombus (LVT). METHODS: A literature search was conducted to identify all case reports of COVID-19 with LVT in PubMed/Medline, Embase, Web of Science, and Google Scholar. RESULTS: Among the 65 patients identified, 60 had LVT, either at admission, or during the acute phase of the illness. Six patients with mild symptoms during the acute phase of viral illness had only the COVID-19 antibody test positivity at the time LV thrombus was detected. Few of the patients (23.1%) had no comorbidities. The mean age of the patients was 52.8 years, and the youngest patient was 4 years old. This suggests that LVT formation can occur in young COVID-19 patients with no co-morbid conditions. Most of the patients (69.2%) had more than one site of thrombosis. A mortality rate of 23.1% was observed in our review, and ST-elevation myocardial infarction (STEMI) was diagnosed in 33.3% of those who died. CONCLUSIONS: A high degree of suspicion for LVT must be maintained in patients with known cardiac disease and those with new-onset arterial or venous thromboembolism, and such patients may benefit from a screening echocardiography at admission. RELEVANCE FOR PATIENTS: The patients with preexisting cardiovascular disease must take added precautions to prevent acquiring COVID-19 infection as there is a higher risk of developing LV thrombus. In patients who develop LVT in COVID-19, mortality rate is higher.
format Online
Article
Text
id pubmed-8715711
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Whioce Publishing Pte. Ltd.
record_format MEDLINE/PubMed
spelling pubmed-87157112022-01-04 A review of the presentation and outcome of left ventricular thrombus in coronavirus disease 2019 infection Philip, Anil Mathew George, Lina James John, Kevin John George, Anu Anna Nayar, Jemimah Sahu, Kamal Kant Selvaraj, Vijairam Lal, Amos Mishra, Ajay Kumar J Clin Transl Res Review Article BACKGROUND: Cardiovascular complications of the coronavirus disease 2019 (COVID-19), which is caused by the severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2), have been documented both in the acute phase and in convalescence. One such complication is the formation of the left ventricular (LV) thrombus. There is a lack of clarity regarding the incidence, risk factors, and management of this complication. AIM: The aim of the study is to identify the clinical presentation, risk factors and outcome of COVID-19 patients with left ventricular thrombus (LVT). METHODS: A literature search was conducted to identify all case reports of COVID-19 with LVT in PubMed/Medline, Embase, Web of Science, and Google Scholar. RESULTS: Among the 65 patients identified, 60 had LVT, either at admission, or during the acute phase of the illness. Six patients with mild symptoms during the acute phase of viral illness had only the COVID-19 antibody test positivity at the time LV thrombus was detected. Few of the patients (23.1%) had no comorbidities. The mean age of the patients was 52.8 years, and the youngest patient was 4 years old. This suggests that LVT formation can occur in young COVID-19 patients with no co-morbid conditions. Most of the patients (69.2%) had more than one site of thrombosis. A mortality rate of 23.1% was observed in our review, and ST-elevation myocardial infarction (STEMI) was diagnosed in 33.3% of those who died. CONCLUSIONS: A high degree of suspicion for LVT must be maintained in patients with known cardiac disease and those with new-onset arterial or venous thromboembolism, and such patients may benefit from a screening echocardiography at admission. RELEVANCE FOR PATIENTS: The patients with preexisting cardiovascular disease must take added precautions to prevent acquiring COVID-19 infection as there is a higher risk of developing LV thrombus. In patients who develop LVT in COVID-19, mortality rate is higher. Whioce Publishing Pte. Ltd. 2021-11-06 /pmc/articles/PMC8715711/ /pubmed/34988332 Text en Copyright: © Whioce Publishing Pte. Ltd. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY-NC-ND 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Philip, Anil Mathew
George, Lina James
John, Kevin John
George, Anu Anna
Nayar, Jemimah
Sahu, Kamal Kant
Selvaraj, Vijairam
Lal, Amos
Mishra, Ajay Kumar
A review of the presentation and outcome of left ventricular thrombus in coronavirus disease 2019 infection
title A review of the presentation and outcome of left ventricular thrombus in coronavirus disease 2019 infection
title_full A review of the presentation and outcome of left ventricular thrombus in coronavirus disease 2019 infection
title_fullStr A review of the presentation and outcome of left ventricular thrombus in coronavirus disease 2019 infection
title_full_unstemmed A review of the presentation and outcome of left ventricular thrombus in coronavirus disease 2019 infection
title_short A review of the presentation and outcome of left ventricular thrombus in coronavirus disease 2019 infection
title_sort review of the presentation and outcome of left ventricular thrombus in coronavirus disease 2019 infection
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8715711/
https://www.ncbi.nlm.nih.gov/pubmed/34988332
work_keys_str_mv AT philipanilmathew areviewofthepresentationandoutcomeofleftventricularthrombusincoronavirusdisease2019infection
AT georgelinajames areviewofthepresentationandoutcomeofleftventricularthrombusincoronavirusdisease2019infection
AT johnkevinjohn areviewofthepresentationandoutcomeofleftventricularthrombusincoronavirusdisease2019infection
AT georgeanuanna areviewofthepresentationandoutcomeofleftventricularthrombusincoronavirusdisease2019infection
AT nayarjemimah areviewofthepresentationandoutcomeofleftventricularthrombusincoronavirusdisease2019infection
AT sahukamalkant areviewofthepresentationandoutcomeofleftventricularthrombusincoronavirusdisease2019infection
AT selvarajvijairam areviewofthepresentationandoutcomeofleftventricularthrombusincoronavirusdisease2019infection
AT lalamos areviewofthepresentationandoutcomeofleftventricularthrombusincoronavirusdisease2019infection
AT mishraajaykumar areviewofthepresentationandoutcomeofleftventricularthrombusincoronavirusdisease2019infection
AT philipanilmathew reviewofthepresentationandoutcomeofleftventricularthrombusincoronavirusdisease2019infection
AT georgelinajames reviewofthepresentationandoutcomeofleftventricularthrombusincoronavirusdisease2019infection
AT johnkevinjohn reviewofthepresentationandoutcomeofleftventricularthrombusincoronavirusdisease2019infection
AT georgeanuanna reviewofthepresentationandoutcomeofleftventricularthrombusincoronavirusdisease2019infection
AT nayarjemimah reviewofthepresentationandoutcomeofleftventricularthrombusincoronavirusdisease2019infection
AT sahukamalkant reviewofthepresentationandoutcomeofleftventricularthrombusincoronavirusdisease2019infection
AT selvarajvijairam reviewofthepresentationandoutcomeofleftventricularthrombusincoronavirusdisease2019infection
AT lalamos reviewofthepresentationandoutcomeofleftventricularthrombusincoronavirusdisease2019infection
AT mishraajaykumar reviewofthepresentationandoutcomeofleftventricularthrombusincoronavirusdisease2019infection